REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Storkpharm Investment Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Merchant Wholesalers, Durable Goods | General Freight Trucking | Warehousing and Storage | Other Depository Credit Intermediation | Scientific Research and Development Services | Office Administrative Services | Other Personal and Household Goods Repair and Maintenance
Full name: Storkpharm Investment Sp. z o.o. Profile Updated: May 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Storkpharm Investment Sp. z o.o. is based in Poland. The head office is in Czestochowa. It operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on August 13, 2018. From the latest financial highlights, Storkpharm Investment Sp. z o.o. reported a net sales revenue increase of 425.21% in 2023. Its total assets grew by 0.48% over the same period. In 2023, Storkpharm Investment Sp. z o.o.’s net profit margin increased by 1510.87%.

Headquarters
Ul. Piastowska 235
Czestochowa; Slaskie; Postal Code: 42-202

Contact Details: Purchase the Storkpharm Investment Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Storkpharm Investment Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Storkpharm Investment Sp. z o.o. report to view the information.
Incorporation Date:
August 13, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Storkpharm Investment Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
425.21%▲
Total operating revenue
405.8%▲
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
84.13%▲
Total assets
0.48%▲
Total equity
-16.41%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
1510.87%▲
Return on Equity (ROE)
-89.29%▼

Similar companies

Adamed Pharma S.A.
 
"Przedsiebiorstwo Produkcji Farmaceutycznej Hasco - Lek" S.A.
Tarchominskie Zaklady Farmaceutyczne "Polfa" S.A.
 
Ziaja Ltd Zaklad Produkcji Lekow Sp. z o.o.
Maco Productions Polonia Sp. z o.o.
 
Orifarm Manufacturing Poland Sp. z o.o.
Fitoemika Sp. z o.o.
 
Graviti Polska Sp. z o.o.
Persefona Sp. z o.o.
 
Medorion Sp. z o.o.
Ringo Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo